299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,696 / Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00719381 (ClinicalTrials.gov)	January 2008	17/7/2008	Effect of Pioglitazone on Inflammation in Cystic Fibrosis	Effect of Pioglitazone on Sputum Biomarkers of Inflammation and Lung Epithelial Repair in Cystic Fibrosis	Cystic Fibrosis	Drug: Pioglitazone	Paul Beringer	NULL	Completed	18 Years	N/A	Both	24	Phase 1	United States
2	NCT00531882 (ClinicalTrials.gov)	September 2007	18/9/2007	Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers	A Pilot Study Evaluating the Effect of Pioglitazone, Simvastatin, and Ibuprofen on Neutrophil Migration in Vivo in Healthy Subjects	Cystic Fibrosis	Drug: Pioglitazone;Drug: Simvastatin;Drug: Ibuprofen	University Hospitals Cleveland Medical Center	NULL	Completed	18 Years	50 Years	All	25	N/A	United States
3	NCT00322868 (ClinicalTrials.gov)	April 2006	4/5/2006	Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease	A Pilot Study Assessing the Safety and Efficacy of Pioglitazone as an Anti-inflammatory Agent for the Treatment of CF Lung Disease in Patients With Cystic Fibrosis	Cystic Fibrosis	Drug: pioglitazone	University Hospitals Cleveland Medical Center	Cystic Fibrosis Foundation	Completed	18 Years	N/A	All	21	N/A	United States